Pacific Biosciences of California (PACB) — Cash Flow Quality Index

Latest as of December 2024: -12.93x

Pacific Biosciences of California (PACB) has a Cash Flow Quality Index of -12.93x as of December 2024. Operating cash flow of $-30.65 Million is below net income of $2.37 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Pacific Biosciences of California assets under control for the complete picture of this company's asset base.

Cash Flow Quality Index

-12.93x
Operating CF / Net Income

Operating Cash Flow

$-30.65 Million
USD

Net Income

$2.37 Million
USD

Data as of

Dec 2024
Most recent filing

Pacific Biosciences of California Cash Flow Quality Index (2020–2020)

Historical Cash Flow Quality Index for Pacific Biosciences of California across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Pacific Biosciences of California tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for Pacific Biosciences of California (2020–2020)

Year-by-year earnings quality comparison for Pacific Biosciences of California. For live market cap and the full company financial profile, see Pacific Biosciences of California (PACB) market capitalisation.

Year Quality Index Operating CF (USD) Net Income YoY Change
2020 0.66x $19.50 Million $29.40 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.